Congenital diaphragmatic hernia: current status and review of the literature

Anthony S de Buys Roessingh1, Anh Tuan Dinh-Xuan

  • 1Service de Chirurgie Pédiatrique, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, 1011, Lausanne, Switzerland. anthony.debuys-roessingh@Chuv.ch

Insights

Congenital diaphragmatic hernia (CDH) treatment is complex. Prenatal tracheal obstruction (TO) and improved postnatal care enhance fetal lung growth and reduce mortality, but challenges remain.

Area of Science:

  • Neonatology
  • Pediatric Surgery
  • Obstetrics

Background:

  • Congenital diaphragmatic hernia (CDH) presents significant challenges in neonatology, pediatric surgery, and obstetrics.
  • High mortality in CDH is linked to persistent pulmonary hypertension (PPHT) and lung hypoplasia, primarily caused by increased pulmonary arteriole muscularization.

Purpose of the Study:

  • To review current management strategies for congenital diaphragmatic hernia.
  • To highlight the impact of prenatal interventions and improved postnatal care on patient outcomes.

Main Methods:

  • Review of current clinical and experimental research on CDH treatment.
  • Analysis of the effects of prenatal tracheal obstruction (TO) and optimized postnatal ventilation.

Main Results:

  • Prenatal TO promotes fetal lung growth, increasing alveoli and capillary vessels.
  • Postnatal care improvements focus on preventing lung injury via low peak inflation pressure ventilation.
  • The efficacy of inhaled nitric oxide and extracorporeal membrane oxygenation (ECMO) remains under debate.

Conclusions:

  • While prenatal interventions and improved postnatal care have advanced CDH management, treatment remains challenging.
  • Further research is needed to establish universally accepted treatment protocols for CDH.